Bolt Biotherapeutics, Inc.
General ticker "BOLT" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $288.1M (TTM average)
Bolt Biotherapeutics, Inc. does not follow the US Stock Market performance with the rate: -11.3%.
Estimated limits based on current volatility of 3.3%: low 4.97$, high 5.30$
Factors to consider:
- Total employees count: 100 (+6.4%) as of 2023
- Top business risk factors: Economic downturns and volatility, Intellectual property risks, Manufacturing disruptions, Labor/talent shortage/retention, Litigation risks
- Current price 11.5% below estimated low
- Earnings for 9 months up through Q3 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [6.00$, 16.47$]
- 2025-12-31 to 2026-12-31 estimated range: [5.37$, 14.69$]
Financial Metrics affecting the BOLT estimates:
- Negative: with PPE of -1.2 at the end of fiscal year the price was high
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -15.48 <= 0.33
- Negative: negative Net income
- Positive: 41.86 < Shareholder equity ratio, % of 57.41 <= 63.39
- Negative: negative Industry operating cash flow (median)
- Positive: Investing cash flow per share per price, % of 14.55 > -0.66
- Positive: Industry inventory ratio change (median), % of 0 <= 0
Short-term BOLT quotes
Long-term BOLT plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $5.73MM | $7.88MM | $7.69MM |
| Operating Expenses | $96.05MM | $84.07MM | $80.74MM |
| Operating Income | $-90.32MM | $-76.20MM | $-73.05MM |
| Non-Operating Income | $2.22MM | $7.00MM | $9.93MM |
| R&D Expense | $73.12MM | $61.54MM | $57.47MM |
| Income(Loss) | $-88.10MM | $-69.20MM | $-63.12MM |
| Profit(Loss)* | $-88.10MM | $-69.20MM | $-63.12MM |
| Stockholders Equity | $171.51MM | $112.74MM | $57.20MM |
| Assets | $227.81MM | $159.78MM | $99.63MM |
| Operating Cash Flow | $-76.50MM | $-69.53MM | $-61.29MM |
| Capital expenditure | $1.95MM | $0.21MM | $0.04MM |
| Investing Cash Flow | $57.86MM | $71.04MM | $57.58MM |
| Financing Cash Flow | $0.50MM | $0.25MM | $0.11MM |
| Earnings Per Share** | $-2.36 | $-1.83 | $-1.65 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.